Jefferies Global Life Sciences Conference Takeaways; Diagnostics

Jefferies hosted its Global Life Sciences Conference last week. Medical devices & diagnostics companies in attendance include: Inverness Medical Innovations

(Buy, $27.69, PT $40) Luminex Corporation

(Buy, $17.50, PT $21) Cepheid

(Buy, $18.28, PT $21) Genomic Health

(Hold, $14.37, PT $18) Gen-Probe

(Buy, $45.12, PT $56) Sequenom

(NC, $6.44) Exact Sciences Corporation

(NC, $4.49) Meridian Bioscience

(NC, $17.35) Most companies were positive about volumes and improving hospital capital spending. A sector-wide concern was a declining Euro and its impact on revenues. Jefferies concluded, "the conference reaffirmed the generally positive outlook for players in the Diagnostics space, despite some near-term set backs such as the EU economic concerns and a weak upcoming flu season."